Cefamandole and cefoxitin

C. V. Sanders, R. N. Greenberg, R. L. Marier

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


Cefamandole and cefoxitin, introduced only 7 years ago, are now the most commonly prescribed parenteral antibiotics in the United States. These drugs are similar to the first-generation cephalosporins in toxicity, but their in-vitro spectrum of activity is greater. Their serum half-lives are longer than those of cephalothin and cephapirin but shorter than that of cefazolin. Although cefamandole has been recommended in empiric therapy for patients with community-acquired pneumonia and as a prophylactic agent for patients having various surgical procedures, other regimens are less expensive and just as effective. Cefamandole should not be used to treat intra-abdominal, enterobacter, or ampicillin-resistant Haemophilus influenzae infections. Cefoxitin is effective in the treatment and prevention of mixed aerobic-anaerobic skin and soft-tissue, intra-abdominal, gynecologic, and penicillinase-producing, spectinomycin-resistant Neisseria gonorrhoeae infections. Cefoxitin represents a greater advance than cefamandole in our continuing search for safe and more effective antimicrobial agents.

Original languageEnglish
Pages (from-to)70-78
Number of pages9
JournalAnnals of Internal Medicine
Issue number1
StatePublished - 1985

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Cefamandole and cefoxitin'. Together they form a unique fingerprint.

Cite this